L-asparagine alleviates osteoarthritis via inhibiting chondrocyte ferroptosis through the p53/SLC7A11/GPX4 pathway
Biochemical Pharmacology · 2026-11 · 118608
DOI: 10.1016/j.bcp.2026.118608 ↗Kurz gefasst
Fachartikel in der Zeitschrift Biochemical Pharmacology, 2026-11. Verfasst von Meifeng Lu und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Sports Medicine, Orthopaedic Hospital , The First Affiliated Hospital, Jiangxi Medical College, Nanchang University, No.17, Yongwai Str…. Die Arbeit nennt 47 Literaturangaben. Gefördert von: Jiangxi Provincial Natural Science Foundation.
Abstract (Originalsprache)
Osteoarthritis (OA) is a prevalent chronic degenerative joint disease, with amino acid metabolic dysregulation and chondrocyte ferroptosis implicated in its pathogenesis. This study aims to investigate the chondroprotective effects of L-asparagine (Asn) and elucidate its molecular mechanisms in targeting ferroptosis. Mendelian randomization (MR) analysis was employed to assess the causal relationship between plasma Asn levels and OA risk, while network pharmacology and transcriptomics were integrated to identify core targets and pathways. The regulatory effects of Asn on ferroptosis and extracellular matrix homeostasis were systematically evaluated in IL-1β-stimulated ATDC5 chondrocytes and a destabilization of the medial meniscus (DMM) mouse model of OA, with Nutlin-3 rescue experiments confirming the involvement of the p53/solute carrier family 7 member 11 (SLC7A11)/glutathione peroxidase 4 (GPX4) axis. Elevated plasma Asn was causally linked to reduced OA risk. In vitro, Asn attenuated IL-1β-induced chondrocyte damage, curtailed reactive oxygen species (ROS) accumulation and lipid peroxidation, and restored mitochondrial ultrastructural integrity, concomitant with upregulated SLC7A11, GPX4, and type II collagen (COL2), alongside downregulated p53, ACSL4, and MMP13-effects that were partially reversed by Nutlin-3 co-administration. In vivo, Asn ameliorated cartilage degeneration and subchondral bone erosion in DMM mice. Collectively, Asn suppresses chondrocyte ferroptosis through the p53/SLC7A11/GPX4 axis, retarding OA progression. These findings provide novel mechanistic evidence and identify a potential therapeutic candidate for the management of OA.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Sports Medicine, Orthopaedic Hospital , The First Affiliated Hospital, Jiangxi Medical College, Nanchang University, No.17, Yongwai Street, Donghu District, Nanchang 330006, China; Graduate School of Jiang…
- Department of Sports Medicine, Orthopaedic Hospital , The First Affiliated Hospital, Jiangxi Medical College, Nanchang University, No.17, Yongwai Street, Donghu District, Nanchang 330006, China.
- Department of Sports Medicine, Orthopaedic Hospital , The First Affiliated Hospital, Jiangxi Medical College, Nanchang University, No.17, Yongwai Street, Donghu District, Nanchang 330006, China. Electronic address: ndsf…
- Department of Sports Medicine, Orthopaedic Hospital , The First Affiliated Hospital, Jiangxi Medical College, Nanchang University, No.17, Yongwai Street, Donghu District, Nanchang 330006, China. Electronic address: ndyf…
Förderung
- Jiangxi Provincial Natural Science Foundation
Zitieren
APA
Lu, M., Zheng, G., Cai, Z., Zhong, D., Chen, S., Sun, G., & Ouyang, Y. (2026). L-asparagine alleviates osteoarthritis via inhibiting chondrocyte ferroptosis through the p53/SLC7A11/GPX4 pathway. Biochemical Pharmacology, 118608. https://doi.org/10.1016/j.bcp.2026.118608
Vancouver
Lu M, Zheng G, Cai Z, Zhong D, Chen S, Sun G, et al. L-asparagine alleviates osteoarthritis via inhibiting chondrocyte ferroptosis through the p53/SLC7A11/GPX4 pathway. Biochemical Pharmacology. 2026:118608. doi:10.1016/j.bcp.2026.118608
BibTeX
@article{Lu2026,
author = {Lu, Meifeng and Zheng, Guihao and Cai, Zichao and Zhong, Duming and Chen, Shuilin and Sun, Guicai and Ouyang, Yulong},
title = {L-asparagine alleviates osteoarthritis via inhibiting chondrocyte ferroptosis through the p53/SLC7A11/GPX4 pathway},
journal = {Biochemical Pharmacology},
year = {2026},
pages = {118608},
doi = {10.1016/j.bcp.2026.118608}
}
EUVIMED